Literature DB >> 19373596

A multi-institutional experience of autologous stem cell transplantation in North American patients with human T-cell lymphotropic virus type-1 adult T-cell leukemia/lymphoma suggests ineffective salvage of relapsed patients.

Adrienne A Phillips, Robert D Willim, David G Savage, Steven M Horwitz, Luis Isola, Jasmine M Zain, Owen A O'Connor.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 19373596     DOI: 10.1080/10428190902887571

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


× No keyword cloud information.
  9 in total

1.  Outcome of patients with HTLV-1-associated adult T-cell leukemia/lymphoma after SCT: a retrospective study by the EBMT LWP.

Authors:  A Bazarbachi; K Cwynarski; A Boumendil; H Finel; P Fields; K Raj; A Nagler; M Mohty; A Sureda; P Dreger; O Hermine
Journal:  Bone Marrow Transplant       Date:  2014-07-14       Impact factor: 5.483

2.  Bortezomib salvage therapy in refractory acute adult T-cell leukemia/lymphoma.

Authors:  Christopher S Hourigan; Patrick M Forde; Richard F Ambinder; Douglas E Gladstone
Journal:  Leuk Lymphoma       Date:  2013-04-19

Review 3.  Striving to cure adult T-cell leukaemia/lymphoma: a role for allogeneic stem cell transplant?

Authors:  E H Phillips; A Hodson; O Hermine; A Bazarbachi; K Cwynarski
Journal:  Bone Marrow Transplant       Date:  2016-09-12       Impact factor: 5.483

4.  Treatment of peripheral T-cell lymphoma: are we data driven or driving the data?

Authors:  Matthew A Lunning; Steven Horwitz
Journal:  Curr Treat Options Oncol       Date:  2013-06

5.  An update on the management of peripheral T-cell lymphoma and emerging treatment options.

Authors:  Adrienne A Phillips; Colette Owens; Sangmin Lee; Govind Bhagat
Journal:  J Blood Med       Date:  2011-09-12

6.  GVHD-free, relapse-free survival provides novel clues for optimizing allogeneic-HSCT for adult T-cell leukemia/lymphoma.

Authors:  Hiroyuki Muranushi; Takero Shindo; Masakatsu Hishizawa; Masahito Tokunaga; Atsushi Wake; Nobuaki Nakano; Tetsuya Eto; Michihiro Hidaka; Ilseung Choi; Toshihiro Miyamoto; Naoyuki Uchida; Yukiyoshi Moriuchi; Yasuhiko Miyazaki; Takahiro Fukuda; Tatsuo Ichinohe; Yoshiko Atsuta; Koji Kato
Journal:  Bone Marrow Transplant       Date:  2020-07-14       Impact factor: 5.483

7.  Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report.

Authors:  Lucy B Cook; Shigeo Fuji; Olivier Hermine; Ali Bazarbachi; Juan Carlos Ramos; Lee Ratner; Steve Horwitz; Paul Fields; Alina Tanase; Horia Bumbea; Kate Cwynarski; Graham Taylor; Thomas A Waldmann; Achilea Bittencourt; Ambroise Marcais; Felipe Suarez; David Sibon; Adrienne Phillips; Matthew Lunning; Reza Farid; Yoshitaka Imaizumi; Ilseung Choi; Takashi Ishida; Kenji Ishitsuka; Takuya Fukushima; Kaoru Uchimaru; Akifumi Takaori-Kondo; Yoshiki Tokura; Atae Utsunomiya; Masao Matsuoka; Kunihiro Tsukasaki; Toshiki Watanabe
Journal:  J Clin Oncol       Date:  2019-01-18       Impact factor: 44.544

Review 8.  Optimizing Management of Patients with Adult T Cell Leukemia-Lymphoma.

Authors:  Jean A Yared; Amy S Kimball
Journal:  Cancers (Basel)       Date:  2015-11-25       Impact factor: 6.639

9.  Adult T-cell leukemia/lymphoma in the Caribbean cohort is a distinct clinical entity with dismal response to conventional chemotherapy.

Authors:  Monica Zell; Amer Assal; Olga Derman; Noah Kornblum; Ramakrishna Battini; Yanhua Wang; Deepa M Narasimhulu; Ioannis Mantzaris; Aditi Shastri; Amit Verma; Hilda Ye; Ira Braunschweig; Murali Janakiram
Journal:  Oncotarget       Date:  2016-08-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.